FI925893A0 - Menetelmä vismutin ja polyakrylaatin vesiliukoisen kompleksin valmistamiseksi - Google Patents
Menetelmä vismutin ja polyakrylaatin vesiliukoisen kompleksin valmistamiseksiInfo
- Publication number
- FI925893A0 FI925893A0 FI925893A FI925893A FI925893A0 FI 925893 A0 FI925893 A0 FI 925893A0 FI 925893 A FI925893 A FI 925893A FI 925893 A FI925893 A FI 925893A FI 925893 A0 FI925893 A0 FI 925893A0
- Authority
- FI
- Finland
- Prior art keywords
- bismuth
- pct
- polyacrylate
- preparation
- water
- Prior art date
Links
- 229910052797 bismuth Inorganic materials 0.000 title abstract 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 title abstract 2
- 229920000058 polyacrylate Polymers 0.000 title abstract 2
- -1 bismuth salts Chemical compound 0.000 abstract 3
- 150000001621 bismuth Chemical class 0.000 abstract 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 1
- 206010019375 Helicobacter infections Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000003904 antiprotozoal agent Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 229960001631 carbomer Drugs 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 229940079905 intestinal adsorbents bismuth preparations Drugs 0.000 abstract 1
- 229960000282 metronidazole Drugs 0.000 abstract 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Saccharide Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909015988A GB9015988D0 (en) | 1990-07-20 | 1990-07-20 | Pharmaceutical composition |
| GB919101675A GB9101675D0 (en) | 1991-01-25 | 1991-01-25 | Pharmaceutical composition |
| GB9103795A GB2253346A (en) | 1991-02-22 | 1991-02-22 | Delayed release oral dosage forms for treatment of intestinal disorders |
| PCT/GB1991/001209 WO1992001457A1 (en) | 1990-07-20 | 1991-07-19 | Products and processes for the treatment of the alimentary canal |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI925893L FI925893L (fi) | 1992-12-28 |
| FI925893A0 true FI925893A0 (fi) | 1992-12-28 |
| FI97952B FI97952B (fi) | 1996-12-13 |
| FI97952C FI97952C (fi) | 1997-03-25 |
Family
ID=27265192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI925893A FI97952C (fi) | 1990-07-20 | 1992-12-28 | Menetelmä vismutin ja polyakrylaatin vesiliukoisen kompleksin valmistamiseksi |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5843482A (fi) |
| EP (1) | EP0540613B1 (fi) |
| JP (1) | JP2688541B2 (fi) |
| KR (1) | KR100193933B1 (fi) |
| AT (1) | ATE135227T1 (fi) |
| AU (1) | AU648574B2 (fi) |
| BG (1) | BG62037B1 (fi) |
| CA (1) | CA2087596A1 (fi) |
| CZ (1) | CZ386292A3 (fi) |
| DE (1) | DE69117955T2 (fi) |
| DK (1) | DK0540613T3 (fi) |
| ES (1) | ES2084174T3 (fi) |
| FI (1) | FI97952C (fi) |
| GB (1) | GB2262286B (fi) |
| GR (1) | GR3019790T3 (fi) |
| HU (1) | HUT64080A (fi) |
| IE (1) | IE65964B1 (fi) |
| NO (2) | NO302684B1 (fi) |
| WO (1) | WO1992001457A1 (fi) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0642797B1 (en) * | 1993-09-09 | 2000-05-17 | Takeda Chemical Industries, Ltd. | Formulation comprising antibacterial substance and antiulcer substance |
| US5549911A (en) * | 1994-01-14 | 1996-08-27 | Laboratoires Des Produits Ethiques Ethypharm | Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract |
| SE502628C2 (sv) * | 1994-02-04 | 1995-11-27 | Nobel Chemicals Ab | Förfarande för framställning av ett vattenlösligt komplex av vismut och en polyakrylsyra |
| US6902738B2 (en) | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
| US5834002A (en) | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
| US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
| GB9414699D0 (en) * | 1994-07-21 | 1994-09-07 | Slagel David | Aqueous foamable composition |
| CA2211873A1 (en) * | 1995-01-26 | 1996-08-01 | Michael Droege | Bismuth compounds |
| GB9501560D0 (en) * | 1995-01-26 | 1995-03-15 | Nycomed Imaging As | Contrast agents |
| US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
| US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
| US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US5744168A (en) * | 1995-12-07 | 1998-04-28 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
| US5827543A (en) * | 1995-12-07 | 1998-10-27 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of urogenital disorders |
| US6051604A (en) * | 1995-12-07 | 2000-04-18 | The Proctor & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
| US5702729A (en) * | 1995-12-07 | 1997-12-30 | The Procter & Gamble Company | Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria |
| CA2239422C (en) * | 1995-12-07 | 2003-03-11 | The Procter & Gamble Company | Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders |
| ATE232736T1 (de) * | 1995-12-07 | 2003-03-15 | Procter & Gamble | Zusammensetzungen zur vorbeugung und behandlung von urogenitalen störungen, die wismut enthalten |
| US5889028A (en) * | 1996-02-09 | 1999-03-30 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
| US5846983A (en) * | 1996-02-09 | 1998-12-08 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
| GB9607955D0 (en) * | 1996-04-17 | 1996-06-19 | Tillotts Pharma Ag | Hydrophobic carbomer salt compositions |
| GB9620709D0 (en) * | 1996-10-04 | 1996-11-20 | Danbiosyst Uk | Colonic delivery of weak acid drugs |
| GB9623962D0 (en) * | 1996-11-15 | 1997-01-08 | Tillotts Pharma Ag | Pharmaceutical composition |
| US6114382A (en) * | 1998-11-11 | 2000-09-05 | Moretti; Itagiba G. | Methods for treating inflammatory bowel disease |
| IN191482B (fi) * | 1999-03-19 | 2003-12-06 | Ranbaxy Lab Ltd | |
| US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
| US7198801B2 (en) | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
| DE60127277T2 (de) * | 2000-08-03 | 2007-11-29 | Antares Pharma Ipl Ag | Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert |
| JP4947851B2 (ja) * | 2001-06-07 | 2012-06-06 | 信紘 佐藤 | 潰瘍性大腸炎治療薬 |
| NZ546106A (en) | 2003-10-10 | 2008-10-31 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
| GB0403247D0 (en) | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
| WO2007124250A2 (en) | 2006-04-21 | 2007-11-01 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
| US8067399B2 (en) | 2005-05-27 | 2011-11-29 | Antares Pharma Ipl Ag | Method and apparatus for transdermal or transmucosal application of testosterone |
| WO2008052294A1 (en) * | 2006-10-30 | 2008-05-08 | Universidade Federal De Minas Gerais | Preparation of compounds of cyclodextrins and derivatives thereof with bismuth compounds |
| US20120053239A1 (en) * | 2006-12-07 | 2012-03-01 | Eli Ehrenpreis | Treatment for intestinal gas, bloating, microscopic colitis, inflammatory bowel disease and traveler's diarrhea using colloidal bismuth subcitrate |
| US7645801B2 (en) | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
| WO2008097851A1 (en) * | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tetracycline compositions for topical administration |
| WO2008097850A1 (en) * | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tretracycline compositions for topical administration |
| RU2605615C2 (ru) * | 2014-07-15 | 2016-12-27 | Общество с ограниченной ответственностью "Гелизовит" | Ректальный поликомплексный гель для лечения язвенного колита, болезни крона, свищей и осложнений, вызванных этими заболеваниями |
| WO2024022447A1 (zh) * | 2022-07-29 | 2024-02-01 | 上海交通大学 | 铋-高分子复合物在消化道可视化中的用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2218934C2 (de) * | 1972-04-19 | 1974-04-18 | Norddeutsche Affinerie | Verfahren zur Vermeidung von Übersättigung der Elektrolytlösungen an einer oder mehreren der Verunreinigungen Arsen, Antimon, Wismut bei der elektrolytischen Raffination von Nichteisenmetallen, insb. Kupfer |
| ZA74385B (en) * | 1974-01-18 | 1975-08-27 | Gist Brocades Nv | Pharmaceutical compositions |
| HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
| EP0217440A1 (en) * | 1985-09-27 | 1987-04-08 | The Procter & Gamble Company | Stable aqueous pharmaceutical suspensions |
| US4837378A (en) * | 1986-01-15 | 1989-06-06 | Curatek Pharmaceuticals, Inc. | Topical metronidazole formulations and therapeutic uses thereof |
| IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
| DE3874917T2 (de) * | 1987-03-09 | 1993-03-04 | Procter & Gamble | Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen. |
| JP2733849B2 (ja) * | 1987-10-12 | 1998-03-30 | ボロディー，ソーマス・ユリウス | 胃腸障害治療のための改良された方法 |
| US4940695A (en) * | 1987-12-10 | 1990-07-10 | The Procter & Gamble Company | Bismuth-containing pharmaceutical compositions |
| GB8817015D0 (en) * | 1988-07-16 | 1988-08-17 | Reckitt & Colmann Prod Ltd | Method of treatment |
| CH679582A5 (fi) * | 1988-07-18 | 1992-03-13 | Glaxo Group Ltd | |
| AU641903B2 (en) * | 1988-10-26 | 1993-10-07 | Glaxo Group Limited | Carboxylic acid derivatives |
| US5128140A (en) * | 1991-01-14 | 1992-07-07 | The Procter & Gamble Company | Swallowable pharmaceutical compositions |
-
1991
- 1991-07-19 WO PCT/GB1991/001209 patent/WO1992001457A1/en not_active Application Discontinuation
- 1991-07-19 DE DE69117955T patent/DE69117955T2/de not_active Expired - Fee Related
- 1991-07-19 AT AT91913651T patent/ATE135227T1/de not_active IP Right Cessation
- 1991-07-19 DK DK91913651.5T patent/DK0540613T3/da active
- 1991-07-19 ES ES91913651T patent/ES2084174T3/es not_active Expired - Lifetime
- 1991-07-19 CA CA002087596A patent/CA2087596A1/en not_active Abandoned
- 1991-07-19 AU AU82348/91A patent/AU648574B2/en not_active Ceased
- 1991-07-19 KR KR1019930700162A patent/KR100193933B1/ko not_active Expired - Fee Related
- 1991-07-19 US US07/966,163 patent/US5843482A/en not_active Expired - Fee Related
- 1991-07-19 HU HU93133A patent/HUT64080A/hu unknown
- 1991-07-19 EP EP91913651A patent/EP0540613B1/en not_active Expired - Lifetime
- 1991-07-19 IE IE254691A patent/IE65964B1/en not_active IP Right Cessation
- 1991-07-19 JP JP3512557A patent/JP2688541B2/ja not_active Expired - Lifetime
- 1991-09-27 CZ CS923862A patent/CZ386292A3/cs unknown
-
1992
- 1992-12-28 FI FI925893A patent/FI97952C/fi active
-
1993
- 1993-01-14 GB GB9300652A patent/GB2262286B/en not_active Expired - Fee Related
- 1993-01-19 NO NO930176A patent/NO302684B1/no not_active IP Right Cessation
- 1993-02-17 BG BG97458A patent/BG62037B1/bg unknown
-
1996
- 1996-04-29 GR GR960401170T patent/GR3019790T3/el unknown
-
1997
- 1997-12-08 NO NO975779A patent/NO306046B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI97952B (fi) | 1996-12-13 |
| GR3019790T3 (en) | 1996-07-31 |
| AU648574B2 (en) | 1994-04-28 |
| JP2688541B2 (ja) | 1997-12-10 |
| NO930176L (no) | 1993-01-19 |
| FI97952C (fi) | 1997-03-25 |
| CA2087596A1 (en) | 1992-01-21 |
| JPH06502431A (ja) | 1994-03-17 |
| IE65964B1 (en) | 1996-01-24 |
| NO302684B1 (no) | 1998-04-14 |
| HU9300133D0 (en) | 1993-04-28 |
| WO1992001457A1 (en) | 1992-02-06 |
| IE912546A1 (en) | 1992-01-29 |
| GB2262286A (en) | 1993-06-16 |
| HUT64080A (en) | 1993-11-29 |
| FI925893L (fi) | 1992-12-28 |
| ATE135227T1 (de) | 1996-03-15 |
| EP0540613B1 (en) | 1996-03-13 |
| ES2084174T3 (es) | 1996-05-01 |
| AU8234891A (en) | 1992-02-18 |
| GB2262286B (en) | 1994-10-12 |
| NO975779D0 (no) | 1997-12-08 |
| US5843482A (en) | 1998-12-01 |
| NO306046B1 (no) | 1999-09-13 |
| EP0540613A1 (en) | 1993-05-12 |
| BG97458A (bg) | 1994-03-31 |
| DK0540613T3 (da) | 1996-04-01 |
| KR100193933B1 (ko) | 1999-06-15 |
| DE69117955D1 (de) | 1996-04-18 |
| CZ386292A3 (en) | 1993-12-15 |
| NO930176D0 (no) | 1993-01-19 |
| NO975779L (no) | 1997-12-08 |
| BG62037B1 (bg) | 1999-01-29 |
| DE69117955T2 (de) | 1996-09-19 |
| GB9300652D0 (en) | 1993-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI97952B (fi) | Menetelmä vismutin ja polyakrylaatin vesiliukoisen kompleksin valmistamiseksi | |
| NZ544583A (en) | Bicyclic peptide imaging agents for in vivo diagnosis or imaging of a disease or condition associated with angiogenesis | |
| SE8306994D0 (sv) | Cefemderivat och forfarande for deras framstellning | |
| GR3004448T3 (fi) | ||
| FI885398A0 (fi) | Menetelmä stabiilin, puristetussa muodossa olevan farmaseuttisen koostumuksen valmistamiseksi | |
| DE3163802D1 (en) | Cephalosporin derivatives, pharmaceutical compositions and process for their preparation | |
| JPS53119844A (en) | Optically active amino acid-mandelic acid complexes and theire preparation | |
| NZ509244A (en) | Treatment regimen for administration of phenylacetylglutamine phenylacetylisoglutamine, and/or phenylacetate | |
| FI960658A0 (fi) | Uudet bis-naftalimidit syövän hoitamiseksi | |
| NZ227990A (en) | Cephemcarboxylic acid esters; pharmaceutical compositions and processes for preparation | |
| ES8401944A1 (es) | Procedimiento para la preparacion de derivados de acido salicilico. | |
| MY100829A (en) | Cyclopentyl ethers and their preparation and pharmaceutical formulation | |
| JPS5536454A (en) | Novel immunosuppressive agent | |
| JPS559053A (en) | Preparation for rectal infusion | |
| ZA912535B (en) | Substituted 3-thia-and 3-oxa-alkylflavones,a process for their preparation,the use thereof,medicaments based on these compounds and intermediates | |
| JPS5695117A (en) | Drug composition having analgesic, antipyretic and anti-infalmmatory action | |
| JPS5315343A (en) | Novel antibiotic derivatives and their preparation | |
| BG95629A (en) | Derivatives of 10, 11, 12, 13 - tetrahytdrodesmicozine, method for preparing them, and their use as pharmaceutical preparations | |
| JPS5210425A (en) | An antibiotic pharmaceutical with low reaction | |
| JPS5731617A (en) | Carcinostatic agent | |
| DK151689D0 (da) | Tc-99m-praeparat til knoglescintigrafi, dets fremstilling og anvendelse | |
| FR2398501A1 (fr) | Nouvelles compositions pharmaceutiques a base de sels organiques mixtes de l'aluminium | |
| SU813922A1 (ru) | 5-метил-9b-окси-2-фенил-1,3,4-тиадиазино /5,6-b/ индол, обладающий противовоспалительной активностью |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: TILLOTTS PHARMA AG |
|
| BB | Publication of examined application |